Valuation: Agilent Technologies, Inc.

Market Cap 44.91B 38.45B 35.96B 32.92B 61.81B 4,298B 62.64B 425B 166B 2,157B 169B 165B 7,137B P/E 2026 *
30.9x
P/E 2027 * 27.1x
Enterprise Value 45.9B 39.3B 36.76B 33.65B 63.17B 4,393B 64.02B 434B 169B 2,204B 172B 169B 7,295B EV / Sales 2026 *
6.16x
EV / Sales 2027 * 5.62x
Free-Float
99.81%
Yield 2026 *
0.65%
Yield 2027 * 0.69%
08-12 Morgan Stanley Adjusts Agilent Technologies PT to $175 From $160, Maintains Overweight Rating MT
07-23 Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers MT
07-21 Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift RE
07-20 HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited CI
07-14 Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma CI
07-14 Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers MT
07-13 Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating MT
07-08 Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis CI
07-06 Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 MT
07-01 Agilent Technologies Launches Xcelligence RTCA Esight AI Module CI
06-26 Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron… Zonebourse
06-25 Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 CI
06-25 Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. CI
1 day+1.73%
1 week+7.05%
Current month+14.91%
1 month+19.67%
3 months+38.51%
6 months+29.37%
Current year+16.85%
1 week 147.19
Extreme 147.19
160.51
1 month 135.78
Extreme 135.78
160.51
Current year 108.35
Extreme 108.35
160.51
1 year 108.35
Extreme 108.35
160.51
3 years 96.43
Extreme 96.43
160.51
5 years 96.43
Extreme 96.43
179.57
10 years 42.92
Extreme 42.92
179.57
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-20
Director of Finance/CFO 49 2025-11-16
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Chairman 75 2017-03-15
Director/Board Member 78 2010-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap.
2/27/26 Tax

Chief Executive Officer

279 0.0001%
2/27/26 Tax

Executive/Senior Manager

89 0.0000%
2/27/26 Tax

Executive/Senior Manager

124 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%+7.05%+35.72%+33.77% 44.91B
+0.27%+6.97%+30.08%+18.23% 233B
+1.36%+8.10%+7.33%-12.52% 154B
+1.16%-3.98%-19.38%+32.14% 134B
+2.03%-2.82%-52.12%-0.10% 73B
-0.04%-1.98%+10.63%+17.63% 51.75B
+0.98%+2.26%-15.88%-11.61% 52.24B
+1.49%-0.36%+41.41%+53.72% 40.35B
+1.03%+1.53%+2.28%+8.48% 33.8B
+1.35%+3.15%-19.71%+39.56% 33.4B
Average +1.14%+1.89%+2.04%+17.93% 84.98B
Weighted average by Cap. +0.99%+3.01%+4.87%+14.36%

Financials

2026 *2027 *
Net sales 7.45B 6.38B 5.96B 5.46B 10.25B 713B 10.39B 70.48B 27.47B 358B 27.96B 27.35B 1,184B 7.9B 6.76B 6.32B 5.79B 10.87B 756B 11.02B 74.72B 29.12B 379B 29.65B 29B 1,255B
Net income 1.46B 1.25B 1.17B 1.07B 2B 139B 2.03B 13.77B 5.37B 69.91B 5.46B 5.35B 231B 1.62B 1.39B 1.3B 1.19B 2.23B 155B 2.26B 15.36B 5.99B 77.99B 6.1B 5.96B 258B
Net Debt 992M 849M 794M 727M 1.36B 94.91B 1.38B 9.38B 3.66B 47.63B 3.72B 3.64B 158B -486M -416M -389M -356M -669M -46.49B -678M -4.6B -1.79B -23.33B -1.82B -1.78B -77.2B
Logo Agilent Technologies, Inc.
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.2%) and services (28.8%). Net sales are distributed geographically as follows: the United States (33.7%), China and Hong Kong (17.6%) and other (48.7%).
Employees
18,000
Date Price Change Volume
26-08-21 US$159.00 +1.73% 2,734,751
26-08-20 US$156.30 +0.57% 2,830,330
26-08-19 US$155.41 +4.70% 3,006,248
26-08-18 US$148.44 -0.01% 1,798,436
26-08-17 US$148.45 -0.05% 964,634
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
159.00USD
Average target price
160.89USD
Spread / Average Target
+1.19%

Quarterly revenue - Rate of surprise